Plantocol Launches Brand and Patent-Pending ATV Protocol for Lupus SLE Symptom Support
The ATV Protocol is a targeted, science-based approach that combines four carefully selected ingredients to address common concerns associated with Lupus SLE, such as fatigue, inflammation, and musculoskeletal discomfort. Designed to work synergistically, the protocol represents a fresh perspective on symptom management, using natural ingredients backed by emerging research.
The ATV Protocol includes:
Vitamin D3 + K2: Studies from the National Institutes of Health (NIH) indicate that Vitamin D3 can play a crucial role in immune system regulation, while Vitamin K2 supports bone health and helps mitigate inflammation—two prevalent concerns for those living with Lupus SLE.
Magnesium Complex: Research published in the Journal of Magnesium Research highlights magnesium's benefits in improving energy levels, reducing muscle pain, and alleviating stress, which are common challenges for Lupus patients.
Trans-Resveratrol 99% Standardized: Peer-reviewed studies from Oxidative Medicine and Cellular Longevity emphasize the antioxidant and anti-inflammatory properties of Trans-Resveratrol, offering relief from oxidative stress and chronic inflammation.
Solanum Dulcamara (Bittersweet Nightshade) Root Extract: Preliminary findings in the Journal of Ethnopharmacology suggest its immunomodulatory effects may help manage joint pain and skin-related symptoms associated with autoimmune conditions.
'Our goal with Plantocol is to empower those living with Lupus SLE by providing a solution rooted in research, innovation, and natural synergy,' said Keven Pimentel, Founder of Plantocol. 'This patent-pending protocol reflects our commitment to advancing natural health while addressing the unique needs of the autoimmune community.'
What distinguishes Plantocol's ATV Protocol is its focus on synergy — ensuring that each component enhances the effectiveness of the others when taken as a complete system. By harnessing this approach, the company aims to provide Lupus SLE patients with a holistic option for symptom support.
The patent application for the ATV Protocol is currently filed with the U.S. Patent Office, underscoring Plantocol's dedication to delivering scientifically-driven, proprietary solutions to the health and wellness market.
Pre-orders are open now, with the first shipment scheduled for June 2025. For more details or to reserve your order, visit www.plantocol.com.
Media Contact
Company Name: Plantocol
Contact Person: Keven Pimentel
Email: Send Email
Country: United States
Website: https://www.plantocol.com/
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
25-06-2025
- Globe and Mail
VSee Health ($VSEE): AI Telehealth Powerhouse Tapped for NIH Stroke Study as It Redefines the $787B Digital Healthcare Market
With Backing from NASA, the U.S. Government, and a $328M Stroke Rehab Opportunity on Deck, VSee Is Quietly Becoming a Major Force in Next-Gen Healthcare Imagine a world where stroke recovery happens from the comfort of home. A world where AI-powered nursing robots reduce hospital costs, and maternal care reaches the most remote corners of the world with just a mobile signal. That's not a futuristic dream—it's the reality VSee Health (Nasdaq: VSEE) is building today. Already trusted by NASA, the U.S. Department of Health and Human Services, McKesson, DaVita, and even the entire nation of Qatar, VSEE is quietly positioning itself as a backbone for digital healthcare infrastructure globally. And now, it's been chosen to support a Phase 3 NIH-funded clinical study on stroke rehabilitation, unlocking a $328 million global market and sending a strong signal to investors: VSEE is a telehealth leader with real-world traction, high-value contracts, and breakout potential. $328M Stroke Rehab Market Now in VSee's Sights On June 23, VSee announced it has been selected to power a UCLA-led, NIH-funded Phase 3 clinical trial for stroke recovery telerehabilitation. The study will include 202 patients across 29 hospitals, testing whether home-based, gamified rehabilitation using VSee's platform can significantly improve arm mobility in stroke survivors—while slashing costs tied to travel, caregivers, and hospital readmissions. 'This is the kind of national, evidence-backed validation investors dream about,' said one industry analyst. If successful, the study could trigger Medicare and private payer reimbursements, opening doors to widespread commercialization in the stroke recovery market—and beyond. VSee's telerehab tools could soon be applied to other high-cost areas like spinal cord injuries, multiple sclerosis, and traumatic brain injuries. From the Philippines to U.S. Hospitals: Scaling Globally with AI VSEE isn't just growing—it's making impact globally. On May 16, the company launched Project MAMA in the remote Philippines, using AI chatbots, portable diagnostic tools, and tele-OB-GYN services to combat maternal mortality in underserved areas. The pilot went live in just four days, demonstrating how fast VSee can deploy critical healthcare infrastructure. Back in the U.S., the company recently unveiled a Telenursing Robotics platform aimed at cutting hospital nursing costs by 3–5%, addressing a $300 billion labor challenge in American healthcare. The solution automates routine nursing tasks, improving patient throughput while relieving overwhelmed hospital staff. Modular, No-Code, "Lego-Like" AI Platform That Scales Fast VSee's biggest edge? Its modular, no-code/low-code platform that allows hospitals and governments to build customized digital health ecosystems without hiring a single engineer. Described as 'Lego-like digital health building blocks,' VSee's technology integrates with major EHR systems (like Oracle Cerner), supports multilingual communication in 240+ languages (via LanguageLine), and powers over 1.5 million HIPAA-compliant video visits per month. This unmatched flexibility is why VSee keeps winning big: $2M hospital contract for neurocritical care robotics. $560K deal with a major oncology network. $444K government mental health platform contract. $6M+ government telehealth deployment agreement —just in its first year. EHR integration with DaVita's top kidney care provider to improve telehealth call success rates by 88%. Telepresence Robots, Unified Health Records & More In addition to NIH trials and hospital contracts, VSee is collaborating with Ava Robotics to bring intelligent telepresence robots to ICUs, allowing doctors to remotely round on patients with real-time video and data. Meanwhile, its partnership with AbundaBox launched AbundaLife™, a revolutionary platform to unify patient medical records into one secure profile—solving the $30B+ fragmentation problem in healthcare data. Built for the Future of Healthcare Whether it's autonomous robotics, remote maternal care, gamified rehab, or multilingual telehealth, VSee isn't reacting to the digital health future—it's building it. With a platform already trusted by the U.S. government, NASA, and a growing list of major healthcare providers, VSee is now positioned to lead in: Investor Takeaway: A Pure-Play AI Telehealth Growth Story VSee Health ($VSEE) stands at the crossroads of AI, telehealth, robotics, and healthcare accessibility—all major investment themes for 2025 and beyond. With clinical validation from the NIH, a growing roster of contracts and partnerships, and a platform that delivers at scale, VSee is more than a telehealth company—it's a digital health infrastructure play. And with the global digital health market projected to hit $787 billion, VSee's current valuation could represent just the beginning. Website: Disclosure listed on the CorporateAds website Media Contact Company Name: Vsee Health, Inc. Contact Person: Anne Chang Email: Send Email Phone: 626-513-1824 Address: One Gateway Center Suite 507 300 Washington St. City: Newton State: Massachusetts Country: United States Website:
National Post
18-06-2025
- National Post
More than 46,000 people observed in a study took their coffee black. Here's what happened to them
Article content However, coffee may not be beneficial for everyone. 'Individuals drinking more than five cups of coffee per day can have an increased risk of myocardial infarction (heart attack) or unstable angina (heart problem causing sudden chest pain),' according to a 2022 study published in the Journal of Personalized Medicine. Researchers at the National Institutes of Health also noted in a 2021 study that 'pregnant women who consumed the caffeine equivalent of as little as half a cup of coffee a day on average had slightly smaller babies than pregnant women who did not consume caffeinated beverages.' Article content One of the limitations of the Tufts' study is that the information used was based on self-reported recall data, which is 'subject to measurement error due to day-to-day variations in food intake.' There was also a lack of significant associations between decaffeinated coffee and all-cause mortality, which could be due to the low consumption among the population studied, per the news release. Article content Article content Zhang, who is the Neely Family Professor at the Friedman School, said in an email to National Post on Tuesday that the driving force behind the research was to address concerns about how coffee additions such as sugars and creams 'may counterbalance coffee's health benefits.' Article content 'Our findings confirm our hypothesis that adding high levels of added sugar and saturated fat make the benefits of coffee consumption lowering mortality risk go away,' she said. Article content She added: 'The key take away is that we need to be mindful about the amount of sugars and saturated fat that we add to coffee when we drink it.' Article content The study is one of the first to quantify the amount of added sugar and saturated fat in coffee. It concluded: 'Although our findings support the health benefits of coffee consumption, the potential negative effects of adding excessive amounts of sugar or saturated fat to coffee warrant public attention.'
CTV News
09-06-2025
- CTV News
NIH scientists publish declaration criticizing Trump's deep cuts in public health research
Jenna Norton ,who works as a researcher at the NIH, poses for a photograph during an interview with the Associated Press in Bethesda, Md., Friday, June 6, 2025. (AP Photo/Jose Luis Magana) WASHINGTON — In his confirmation hearings to lead the National Institutes of Health, Jay Bhattacharya pledged his openness to views that might conflict with his own. 'Dissent,' he said, 'is the very essence of science.' That commitment is being put to the test. On Monday, scores of scientists at the agency sent their Trump-appointed leader a letter titled the Bethesda Declaration, a frontal challenge to 'policies that undermine the NIH mission, waste public resources, and harm the health of Americans and people across the globe.' It says: 'We dissent.' In a capital where insiders often insist on anonymity to say such things publicly, more than 90 NIH researchers, program directors, branch chiefs and scientific review officers put their signatures on the letter — and their careers on the line. Confronting a 'culture of fear' They went public in the face of a 'culture of fear and suppression' they say President Donald Trump's administration has spread through the federal civil service. 'We are compelled to speak up when our leadership prioritizes political momentum over human safety and faithful stewardship of public resources,' the declaration says. Named for the agency's headquarters location in Maryland, the Bethesda Declaration details upheaval in the world's premier public health research institution over the course of mere months. It addresses the abrupt termination of 2,100 research grants valued at more than $12 billion and some of the human costs that have resulted, such as cutting off medication regimens to participants in clinical trials or leaving them with unmonitored device implants. In one case, an NIH-supported study of multi-drug-resistant tuberculosis in Haiti had to be stopped, ceasing antibiotic treatment mid-course for patients. In a number of cases, trials that were mostly completed were rendered useless without the money to finish and analyze the work, the letter says. 'Ending a $5 million research study when it is 80% complete does not save $1 million,' it says, 'it wastes $4 million.' The mask comes off The four-page letter, addressed to Bhattacharya but also sent to Health Secretary Robert F. Kennedy Jr. and members of Congress who oversee the NIH, was endorsed by 250 anonymous employees of the agency besides the 92 who signed. Jenna Norton, who oversees health disparity research at the agency's National Institute of Diabetes and Digestive and Kidney Diseases, recently appeared at a forum by Sen. Angela Alsobrooks, D-Md., to talk about what's happening at the NIH. At the event, she masked to conceal her identity. Now the mask is off. She was a lead organizer of the declaration. 'I want people to know how bad things are at NIH,' Norton told The Associated Press. The signers said they modeled their indictment after Bhattacharya's own Great Barrington Declaration of October 2020, when he was a professor at Stanford University Medical School. His declaration drew together likeminded infectious disease epidemiologists and public health scientists who dissented from what they saw as excessive COVID-19 lockdown policies and felt ostracized by the larger public health community that pushed those policies, including the NIH. 'He is proud of his statement, and we are proud of ours,' said Sarah Kobrin, a branch chief at the NIH's National Cancer Institute who signed the Bethesda Declaration. Cancer research is sidelined As chief of the Health Systems and Interventions Research Branch, Kobrin provides scientific oversight of researchers across the country who've been funded by the cancer institute or want to be. But sudden cuts in personnel and money have shifted her work from improving cancer care research to what she sees as minimizing its destruction. 'So much of it is gone — my work,' she said. The 21-year NIH veteran said she signed because 'I don't want to be a collaborator' in the political manipulation of biomedical science. Ian Morgan, a postdoctoral fellow with the National Institute of General Medical Sciences, also signed the declaration. 'We have a saying in basic science,' he said. 'You go and become a physician if you want to treat thousands of patients. You go and become a researcher if you want to save billions of patients. 'We are doing the research that is going to go and create the cures of the future,' he added. But that won't happen, he said, if Trump's Republican administration prevails with its searing cuts to grants. The NIH employees interviewed by the AP emphasized they were speaking for themselves and not for their institutes or the NIH. Dissenters range across the breadth of NIH Employees from all 27 NIH institutes and centers gave their support to the declaration. Most who signed are intimately involved with evaluating and overseeing extramural research grants. The letter asserts that 'NIH trials are being halted without regard to participant safety' and that the agency is shirking commitments to trial participants who 'braved personal risk to give the incredible gift of biological samples, understanding that their generosity would fuel scientific discovery and improve health.' The Trump administration has gone at public health research on several fronts, both directly, as part of its broad effort to root out diversity, equity and inclusion values throughout the bureaucracy, and as part of its drive to starve some universities of federal money. A blunt ax swings This has forced 'indiscriminate grant terminations, payment freezes for ongoing research, and blanket holds on awards regardless of the quality, progress, or impact of the science,' the declaration says. Some NIH employees have previously come forward in televised protests to air grievances, and many walked out of Bhattacharya's town hall with staff. The declaration is the first cohesive effort to register agency-wide dismay with the NIH's direction. A Signal group became the place for participants to sort through NIH chatter on Reddit, discern rumor from reality and offer mutual support. The declaration took shape in that group and as word spread neighbor to neighbor in NIH offices. The dissenters remind Bhattacharya in their letter of his oft-stated ethic that academic freedom must be a lynchpin in science. With that in place, he said in a statement in April, 'NIH scientists can be certain they are afforded the ability to engage in open, academic discourse as part of their official duties and in their personal capacities without risk of official interference, professional disadvantage or workplace retaliation.' Now it will be seen whether that's enough to protect those NIH employees challenging the Trump administration and him. 'There's a book I read to my kids, and it talks about how you can't be brave if you're not scared,' said Norton, who has three young children. 'I am so scared about doing this, but I am trying to be brave for my kids because it's only going to get harder to speak up. 'Maybe I'm putting my kids at risk by doing this,' she added. 'And I'm doing it anyway because I couldn't live with myself otherwise.' ___ Associated Press Medical Writer Lauran Neergaard contributed to this report. Calvin Woodward And Nathan Ellgren, The Associated Press
